Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02002858 · ClinicalTrials.gov registry record · Phase 1
Smoking Cessation for Depression and Anxiety Treatment
A Phase 1 study, sponsored by University of Houston.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT02002858 is a Phase 1 study that has completed, run by University of Houston. The registered enrollment target is 12 participants.
The verdict
NCT02002858, a Phase 1 study, has completed, sponsored by University of Houston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The primary aim of this research study is to enhance smoking cessation outcome among smokers with elevated anxiety and depression. We are comparing two group treatment approaches: (1) An educational-supportive psychotherapy and standard smoking cessation treatment, and (2) An integrated smoking cessation, and anxiety and depression management treatment program (SDAT). Both treatments also utilize nicotine replacement therapy.
Interventions
- DRUG Nicotine Patch
- BEHAVIORAL Depression and Anxiety Smoking Cessation Treatment
- BEHAVIORAL Educational-Support Psychotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-10 |
| Est. Completion | 2017-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02002858
The ClinicalTrials.gov registry entry for NCT02002858 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Houston, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Nicotine Patch is the first listed.
NCT02002858 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02002858 about?
NCT02002858 is a clinical study titled "Smoking Cessation for Depression and Anxiety Treatment". The primary aim of this research study is to enhance smoking cessation outcome among smokers with elevated anxiety and depression. We are comparing two group treatment approaches: (1) An educational-supportive psychotherapy and standard smoking cessation treatment, and (2) An integrated smoking cess...
What is the current status of trial NCT02002858?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2014-10. Estimated completion is 2017-05.
What interventions are being tested in trial NCT02002858?
The interventions under investigation include: Nicotine Patch (DRUG), Depression and Anxiety Smoking Cessation Treatment (BEHAVIORAL), Educational-Support Psychotherapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02002858?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.